Related Experiment Video
Updated: May 14, 2026

Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
Smart Wheelchair and Sensor System for Tracking Performance and Accessibility in Urban Environments
Franz Konstantin Fuss1,2, Adin Ming Tan1, Oren Tirosh3
1Chair of Biomechanics, Faculty of Engineering Science, University of Bayreuth, D-95447 Bayreuth, Germany.
None:
Wheelchair users face significant mobility limitations related to both medical issues (e.g., musculoskeletal strain, pressure ulcers) and urban accessibility challenges. This pilot study introduces a sensor system integrating an inertial measurement unit (IMU), GPS (Global Positioning System), and a pressure-measuring seat to monitor distance travelled, speed, and posture in relation to real-world conditions. Seven participants navigated an approximately 800-metre outdoor course, divided into 13 sections, while real-time data were recorded. The results showed an average speed of 1.24 ± 0.41 m/s with peak speeds of up to 2.67 m/s. The centre of pressure on the seat fluctuated by an average of 25 mm in the x and y directions (left-right: COPx, back-forward: COPy). The data for average speed, COPx, and COPy showed significant differences between most of the 13 sections, with large, very large, and huge effect sizes. Comparing the speed, COPx, and COPy data with respect to distance travelled, and correlating them between the seven participants by applying the rank-sum method to the mean R2 and calculating Kendall's W, revealed that speed, COPx, and COPy were influenced by course conditions (R2 medians between 0.013 and 0.499; W = 0.7857, strong agreement; χ2p = 0.0281). Small R2 values indicate more individualised participant behaviour, while large R2 values highlight the stronger influence of course conditions on the parameters. This non-invasive and cost-effective system provides objective motion data that can be used for future research in wheelchair design and rehabilitation strategies. Despite its advantages, this study was limited to able-bodied participants, so further clinical trials with individuals with mobility impairments are needed.
